These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 680392)

  • 1. Production of inactivated rabies vaccine for human use on WI38 diploid cells. Results of potency tests. Stability of the vaccine in liquid and freeze-dried forms.
    Nicolas AJ; Patet J; Falquet JC; Branche R; Delaiti P; Montagnon B; Peyron L; Soulebot JP
    Dev Biol Stand; 1978; 40():17-24. PubMed ID: 680392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Counterimmunoelectrophoresis technique for determining the antigenic potency of rabies vaccine].
    Miceli G; Torroba JE; Diaz AM
    Rev Inst Med Trop Sao Paulo; 1993; 35(6):543-50. PubMed ID: 7997759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stability of yellow fever vaccine.
    Monath TP
    Dev Biol Stand; 1996; 87():219-25. PubMed ID: 8854020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of the antibody assay in immunized mice for the determination of rabies vaccine potency.
    Fitzgerald EA; Gallagher M; Hunter WS; Seligmann EB
    Dev Biol Stand; 1978; 40():183-6. PubMed ID: 355013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Production of an inactivated rabies vaccine in primary dog kidney cells.
    van Wezel AL; van Steenis G
    Dev Biol Stand; 1978; 40():69-75. PubMed ID: 98375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stability of freeze-dried and reconstituted measles vaccines.
    Peetermans J; Colinet G; Stephenne J; Bouillet A
    Dev Biol Stand; 1978; 41():259-64. PubMed ID: 753654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potency testing of diploid-cell rabies vaccine and correlation with immunogenicity.
    Tint H; Rosanoff EI
    Dev Biol Stand; 1978; 40():195-201. PubMed ID: 680393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stability of live, freeze-dried virus vaccines.
    Peetermans J; Colinet G; Bouillet A; D'Hondt E; Stephenne J
    Dev Biol Stand; 1976 Oct; 36():291-6. PubMed ID: 1030427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody levels following WI38 rabies vaccine.
    Cabasso VJ; Louie RE; Lo B; Dobkin MB
    Dev Biol Stand; 1978; 40():231-5. PubMed ID: 355016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative determination of rabies antigen by ELISA.
    van der Marel P; van Wezel AL
    Dev Biol Stand; 1981; 50():267-75. PubMed ID: 7341294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison studies on potency tests for rabies vaccines.
    Wiktor TJ; Atanasiu P; Bahmanyar M; Boegel K; Cox JH; Diaz AM; Fitzgerald EA; Kuwert E; Netter R; Selimov M; Turner G; van Steenis G
    Dev Biol Stand; 1978; 40():171-8. PubMed ID: 355011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Potency testing of inactivated rabies vaccines with the antibody binding test in comparison with the NIH and habel test(author's transl)].
    Oei HL; Krauss H
    Zentralbl Bakteriol Orig A; 1975; 231(1-3):1-14. PubMed ID: 1154901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Thermostability of rabies vaccine, type Fuenzalida & Palacios, for human use].
    Albas A; Fuches RM; Gallina NM; Mendonça RM; Fang FL; Valentini EJ
    Rev Inst Med Trop Sao Paulo; 1992; 34(1):27-31. PubMed ID: 1284895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of the single radial immunodiffusion test as a replacement for the NIH mouse potency test for rabies vaccine.
    Fitzgerald EA; Needy CF
    Dev Biol Stand; 1986; 64():73-9. PubMed ID: 3098606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of storage at 37 degrees C on allergenic potency of dried BCG vaccine.
    OBAYASHI Y; CHO C; YOSHIOKA T; KAWASAKI J; SHIMAO T
    Bull World Health Organ; 1957; 17(2):275-86. PubMed ID: 13489468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sorbitol-gelatin and glutamic acid-lactose solutions for stabilization of reference preparations of measles virus.
    de Rizzo E; Tenório EC; Mendes IF; Fang FL; Pral MM; Takata CS; Miyaki C; Gallina NM; Tuchiya HN; Akimura OK
    Bull Pan Am Health Organ; 1989; 23(3):299-305. PubMed ID: 2571379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potency evaluation of rabies vaccine for human use: the impact of the reduction in the number of animals per dilution.
    de Moura WC; de Araujo HP; Cabello PH; Romijn PC; Leite JP
    J Virol Methods; 2009 Jun; 158(1-2):84-92. PubMed ID: 19428574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Production of rabies vaccine by an industrial scale BHK 21 suspension cell culture process.
    Pay TW; Boge A; Menard FJ; Radlett PJ
    Dev Biol Stand; 1985; 60():171-4. PubMed ID: 3899780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of residual moisture in lyophilized smallpox vaccine on its stability at different temperatures.
    Sparkes JD; Fenje P
    Bull World Health Organ; 1972; 46(6):729-34. PubMed ID: 4538534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Production in Vero cells of an inactivated rabies vaccine from strain FRV/K for animal and human use.
    el-Karamany RM
    Acta Virol; 1987 Aug; 31(4):321-8. PubMed ID: 2892381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.